Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review
- PMID: 12676842
- PMCID: PMC152634
- DOI: 10.1136/bmj.326.7392.737
Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review
Abstract
Objectives: To ascertain the prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease and its association with the disease.
Design: Systematic review of studies reporting the prevalence of H pylori in patients with and without gastro-oesophageal reflux disease.
Data sources: Four electronic databases, searched to November 2001, experts, pharmaceutical companies, and journals.
Main outcome measure: Odds ratio for prevalence of H pylori in patients with gastro-oesophageal reflux disease.
Results: 20 studies were included. The pooled estimate of the odds ratio for prevalence of H pylori was 0.60 (95% confidence interval 0.47 to 0.78), indicating a lower prevalence in patients with gastro-oesophageal reflux disease. Substantial heterogeneity was observed between studies. Location seemed to be an important factor, with a much lower prevalence of H pylori in patients with gastro-oesophageal reflux disease in studies from the Far East, despite a higher overall prevalence of infection than western Europe and North America. Year of study was not a source of heterogeneity.
Conclusion: The prevalence of H pylori infection was significantly lower in patients with than without gastro-oesophageal reflux, with geographical location being a strong contributor to the heterogeneity between studies. Patients from the Far East with reflux disease had a lower prevalence of H pylori infection than patients from western Europe and North America, despite a higher prevalence in the general population.
Figures


Comment in
-
Helicobacter pylori in gastro-oesophageal reflux disease needs comparator.BMJ. 2003 Jun 28;326(7404):1460. doi: 10.1136/bmj.326.7404.1460. BMJ. 2003. PMID: 12829575 Free PMC article. No abstract available.
Similar articles
-
Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.Aliment Pharmacol Ther. 2004 Oct 1;20(7):733-44. doi: 10.1111/j.1365-2036.2004.02172.x. Aliment Pharmacol Ther. 2004. PMID: 15379833
-
The Role of Helicobacter pylori in Laryngopharyngeal Reflux.Otolaryngol Head Neck Surg. 2017 Feb;156(2):255-262. doi: 10.1177/0194599816676052. Epub 2016 Nov 1. Otolaryngol Head Neck Surg. 2017. PMID: 27803078
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
Cisapride treatment for gastro-oesophageal reflux in children.Cochrane Database Syst Rev. 2003;(4):CD002300. doi: 10.1002/14651858.CD002300. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD002300. doi: 10.1002/14651858.CD002300.pub2. PMID: 14583950 Updated.
-
Cisapride treatment for gastro-oesophageal reflux in children.Cochrane Database Syst Rev. 2002;(3):CD002300. doi: 10.1002/14651858.CD002300. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2003;(4):CD002300. doi: 10.1002/14651858.CD002300. PMID: 12137654 Updated.
Cited by
-
The implications of Helicobacter pylori infection for gastroesophageal reflux disease: studies presented at Digestive Disease Week 2003.Curr Gastroenterol Rep. 2004 Jun;6(3):191-5. doi: 10.1007/s11894-004-0005-6. Curr Gastroenterol Rep. 2004. PMID: 15128483
-
Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients.Dig Dis Sci. 2008 Aug;53(8):2033-8. doi: 10.1007/s10620-007-0114-9. Epub 2007 Dec 13. Dig Dis Sci. 2008. PMID: 18080197 Clinical Trial.
-
Barrett esophagus in Asia: same disease with different pattern.Clin Endosc. 2014 Jan;47(1):15-22. doi: 10.5946/ce.2014.47.1.15. Epub 2014 Jan 24. Clin Endosc. 2014. PMID: 24570879 Free PMC article. Review.
-
Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans.J Neurogastroenterol Motil. 2011 Jul;17(3):267-73. doi: 10.5056/jnm.2011.17.3.267. Epub 2011 Jul 13. J Neurogastroenterol Motil. 2011. PMID: 21860818 Free PMC article.
-
Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA.Gut Pathog. 2016 Mar 15;8:8. doi: 10.1186/s13099-016-0091-7. eCollection 2016. Gut Pathog. 2016. PMID: 26981156 Free PMC article. Review.
References
-
- Jones R. Gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol Suppl. 1995;211:35–38. - PubMed
-
- Office of Health Economics. Health expenditures in the UK. London: Stationery Office; 1996.
-
- Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung AF, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994;343:508–510. - PubMed
-
- Graham DY, Yamaoka Y. H pylori and cagA. Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998;3:145–151. - PubMed
-
- Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol. 1998;93:1800–1802. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical